HIV non-testing, perpetration of violence against women, and sexual risk-behaviour: A cross-sectional analysis of South African peri-urban township men.
Teurai Rwafa-PonelaRuari-Santiago McBrideDumisani RebomboNicola ChristofidesAbigail HatcherPublished in: Global public health (2021)
Despite HIV testing having improved globally, men remain disproportionately less likely to test for HIV. While violence against women (VAW) and HIV risk have a strong association among women, few studies explore men around VAW perpetration, risky-sexual behaviour, and HIV testing. Males aged 18-42 years were recruited from a peri-urban settlement near Johannesburg, South Africa. Data were from an endline of a trial. We used logistic regression to assess odds of non-HIV testing using STATA 13. At endline, 1508 men participated in the study. Of these nearly one-third (31.6%, n = 475) had not tested for HIV in the past year. HIV non-testing was significantly lower among men who were single, older, did not complete high school and were less food secure. VAW perpetration retained a significant association with HIV non-testing after controlling for socio-demographics (AOR = 0.73, 95%CI = 0.58-0.93). In multivariate models, HIV non-testing was also associated with inconsistent condom use (AOR = 0.64, 95%CI = 0.48-0.85), problem drinking (AOR = 0.72, 95%CI = 0.55-0.94) and reporting of all four risky sexual behaviours (AOR = 0.70, 95%CI = 0.49-1.01). Data suggests that one-third of men who never test for HIV in this setting may represent a high-risk group. Future campaigns could consider behaviour change around non-violence, relationship quality, and gender norms alongside HIV testing.
Keyphrases
- hiv testing
- men who have sex with men
- hiv positive
- mental health
- south africa
- middle aged
- human immunodeficiency virus
- clinical trial
- intimate partner violence
- polycystic ovary syndrome
- hepatitis c virus
- randomized controlled trial
- insulin resistance
- study protocol
- pregnancy outcomes
- hiv aids
- open label
- risk assessment
- adverse drug
- double blind
- cervical cancer screening